Kevin Rakin

Kevin Rakin

Founder en ELUTIA INC. .

Fortuna: 8 M $ al 31/03/2024

63 años
Health Technology
Finance
Commercial Services

Perfil

Kevin L.
Rakin
is the founder of Helix Therapeutics, Inc. (founded in 2006), Genaissance Pharmaceuticals, Inc. (founded in 1998), HighCape Partners Management LLC (founded in 2013), Elutia, Inc. (founded in 2015), and Cybrexa, Inc. (founded in 2016).
He held various titles at Genaissance Pharmaceuticals, Inc., including President & Chief Executive Officer from 1998 to 2005.
Mr. Rakin is also the founder of HighCape Capital LP.
Mr. Rakin's current job(s) include Chairman & Chief Executive Officer at HighCape Capital Acquisition Corp.
II (since 2021), Chairman at Wellinks, Inc., Director at Cyvek, Inc. (since 2012), Independent Non-Executive Director at Nyxoah SA (since 2016), Director at Convexity Scientific, Inc. (since 2017), President & Director at Aztek Bio LLC, and Director at Quantum-Si, Inc. (since 2020).
Mr. Rakin's former job(s) include Chief Executive Officer at Shire Regenerative Medicine, Inc. (2007-2011), Chief Executive Officer at Canaan Management, Inc. (2006-2007), Chairman & Chief Executive Officer at HighCape Capital Acquisition Corp.
(2020-2021), Chairman at Oramed Pharmaceuticals, Inc. (2016-2022), Chairman at Athena Therapeutics LLC, Director at Clinical Data, Inc., Director at Vion Pharmaceuticals, Inc. (2007-2010), Director at OMRIX Biopharmaceuticals, Inc. (2007-2008), Independent Director at Histogenics Corp.
(2012-2019), Director at Cheetah Medical, Inc., Director at TELA Bio, Inc., Director at Sciona, Inc., Director at QIAGEN Marseille SA, Director at Collagen Matrix, Inc., President at Shire Regenerative Medicine, Inc. (2011-2012), and President-Regenerative Medicine at Shire Plc (2011-2012).
He was also an Advisor at Red Abbey Venture Partners LLC and a Principal at The Stevenson Group (1990-1997).
Mr. Rakin's education includes undergraduate and graduate degrees from the University of Cape Town and an MBA from Columbia Business School.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
01/03/2024 2 909 924 ( 2.39% ) 6 M $ 31/03/2024
18/03/2024 148 500 ( 0.52% ) 2 M $ 31/03/2024
28/12/2023 90 807 ( 0.45% ) 286 042 $ 31/03/2024

Cargos activos de Kevin Rakin

EmpresasCargoInicio
ELUTIA INC. Founder 06/08/2015
NYXOAH SA Director/Board Member 29/06/2016
QUANTUM-SI INCORPORATED Director/Board Member 10/06/2020
Director/Board Member 01/01/2017
Chief Executive Officer 01/02/2021
Director/Board Member 01/01/2012
Todos los cargos activos de Kevin Rakin

Antiguos cargos conocidos de Kevin Rakin.

EmpresasCargoFin
Consultant / Advisor 23/12/2022
ORAMED PHARMACEUTICALS INC. Chairman 30/06/2022
HIGE CAPI Chief Executive Officer 10/06/2021
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Kevin Rakin.

Formación de Kevin Rakin.

University of Cape Town Graduate Degree
Columbia Business School Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kevin Rakin.

Relaciones

100 +

Relaciones de 1er grado

27

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas5
TELA BIO, INC.

Health Technology

ELUTIA INC.

Health Technology

NYXOAH SA

Health Technology

ORAMED PHARMACEUTICALS INC.

Health Technology

QUANTUM-SI INCORPORATED

Technology Services

Empresas privadas20

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Health Technology

Finance

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Transportation

Finance

Finance

Health Technology

Health Technology

Ver las conexiones de la empresa